Healthy foods may matter more than weight alone.
If you’ve ever made a genuine, perhaps painstaking, effort to eat healthier, only to find that your weight doesn’t budge, it’s easy to feel like you’re failing. Or like your body…

Healthy foods may matter more than weight alone.
If you’ve ever made a genuine, perhaps painstaking, effort to eat healthier, only to find that your weight doesn’t budge, it’s easy to feel like you’re failing. Or like your body…

WASHINGTON, DC – FEBRUARY 13: Robert F. Kennedy Jr. speaks after being sworn in as Secretary of … More

The Affordable Care Act is going through market upheaval as Aetna announces its departure from the … More
The House budget reconciliation…

Blood clots can form in both arteries and veins. However, the reasons behind them differ, as do the consequences and the chances of preventing blood clots. In Sweden, almost half of all cases of venous thrombosis have a genetic explanation. A…

Marijuana use among older adults in the US has reached a new high, with 7 percent of adults aged 65 and over who report using it in the past month, according to an analysis led by researchers with the Center for Drug Use and HIV/HCV Research…

When DNA breaks inside the cell, it can spell disaster, especially if the damage occurs in areas of the genome that are difficult to repair. Now, scientists Irene Chiolo and Chiara Merigliano at the USC Dornsife College of Letters, Arts and…

The American Medical Association says legislation wending its way through the Republican-controlled … More

Following a low calorie diet is linked to a heightened risk of depressive symptoms, finds research published in the open access journal, BMJ Nutrition Prevention & Health.
Men and those who are overweight may be especially vulnerable to the…

In the name of open science, the multinational scientific collaboration COSMOS on Thursday released the data behind the largest map of the universe. Called the COSMOS-Web field, the project, built with data collected by the James Webb Space…

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published on June 4 by The BMJ.